BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Ultimate Trader

1 year 30%, 2 years 40% and *3 years 40%

*Across 3 years $3395.52 only $1697.76

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,032.38
      0.56%
      US Tech 100
      20,389.60
      0.88%
      Dow Jones
      44,910.65
      0.42%
      Brent Oil
      72.04
      0.00%
      Bitcoin
      96,791.58
      -0.71%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Iovance Biotherapeutics Inc (IOVA)

      7. Iovance Biotherapeutics Inc (IOVA) Financials

      Iovance Biotherapeutics Inc

      Iovance Biotherapeutics Inc (IOVA)

      NASDAQ
      9.32
      -0.08
      (-0.85%)
      Closed November 30 4:00PM
      Delayed by 15 minutes
      9.35
      0.03
      (0.32%)
      After Hours: 5:00PM
      Delayed by 15 minutes

      Iovance Biotherapeutics Inc Financial Summary

      The current IOVA market cap is 2.84B. The company's latest EPS is USD -1.4569 and P/E is -6.40.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 238k469k482k715k31.11M
      Operating Income -110.09M-118.36M-121.26M-117.72M-101.91M
      Net Income -106.53M-113.76M-116.38M-112.98M-97.1M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00001.19M
      Operating Income -206.87M-261.94M-342.7M-398.88M-460.56M
      Net Income -197.56M-259.58M-342.25M-395.89M-444.04M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 757.29M852.32M780.35M869.83M964.32M
      Total Liabilities 178.72M178.31M195.74M189.81M195.78M
      Total Equity 578.57M674.01M584.61M680.02M768.54M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 344.66M768.46M777.33M663.98M780.35M
      Total Liabilities 45.68M111.96M155.67M164.34M195.74M
      Total Equity 298.97M656.5M621.66M499.64M584.61M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -193.77M-277.85M-361.82M-122.28M-220.71M
      Investing -3.38M-82.4M-155.24M-111.51M-71.29M
      Financing 259.2M462M462.96M193.58M346.4M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -158.89M-205.13M-227.94M-292.76M-361.82M
      Investing 90.03M-317.85M132k256.46M-155.24M
      Financing 6.13M576.42M239.27M190.15M462.96M

      Stats and Ratios

      Market Cap 2.84B
      Price to Earnings Ratio -6.40
      Price to Sales Ratio 2.39k
      Price to Cash Ratio 24.72
      Price to Book Ratio 4.86
      Dividend Yield -

      Share Statistics

      Shares Outstanding 304.78M
      Average Volume (1 week) 7.44M
      Average Volume (1 Month) 9.32M
      52 Week Change 66.13%
      52 Week High 18.33
      52 Week Low 5.61
      Spread (Intraday) 0.06 (0.64%)

      Company Info

      Company Name Iovance Biotherapeutics Inc
      Address 2140 s dupont hwy
      camden, delaware 19934
      Website https://www.iovance.com
      Industry biological pds,ex diagnstics (2836)

      Your Recent History

      NASDAQ
      IOVA
      Iovance Biotherapeutics
      Delayed Upgrade Clock